Atvo Enterprises has scheduled its 31st Annual General Meeting for September 29, 2026, to approve financial results for the fiscal year ended March 31, 2026. The textile manufacturer reported a significant jump in profitability, driven by higher operational income and interest receipts.

Financial Performance

The company reported total turnover of ₹675.33 lakh for FY26, an increase from ₹517.14 lakh in the previous year. This growth was primarily fueled by a rise in income from business operations, which climbed to ₹598.24 lakh from ₹444.80 lakh.

Net profit after tax more than doubled to ₹21.49 lakh from ₹11.41 lakh in FY25. Earnings per share increased to ₹0.02 from ₹0.01. The board did not recommend any dividend for the year, opting to retain profits for future business plans.

What the Numbers Show

A key observation in the financials is the substantial contribution of non-operating income to the bottom line. Other income stood at ₹77.08 lakh, which exceeded the profit before depreciation and tax of ₹29.51 lakh. This indicates that the company's net profitability is heavily supported by interest or other non-core receipts rather than operational margins alone. Additionally, trade receivables surged to ₹158.65 lakh from ₹36.60 lakh, suggesting a potential increase in working capital requirements or slower collection cycles amidst revenue growth.

Corporate Governance and Compliance

The secretarial audit report highlighted several compliance lapses during the fiscal year. The company failed to publish financial results in newspapers as required under SEBI Listing Regulations and delayed the submission of financial results to the stock exchange. There were also delays in submitting AGM proceedings and explanations for result delays. The board has acknowledged these issues and stated it has strengthened internal compliance monitoring mechanisms.

Board Changes

The board composition saw changes during the year. Mrs. Charul Gattani resigned as Executive Director on August 30, 2025. Subsequently, Mr. Siddharth Gattani and Mr. Shorya Gattani were appointed as Executive Directors effective the same date. Mr. Siddharth Gattani retires by rotation at the upcoming AGM and offers himself for re-appointment. The board met six times during the year, with all directors attending all meetings they were eligible for.

Atvo Enterprises board approved the scheme of amalgamation of Atvo Agrochem Limited, Shubhshree Health Care Private Limited, and Shorya Business (India) Limited on August 26, 2026. The move consolidates the group’s ethanol, alcohol, and real estate assets under the listed entity.

The Board considered and approved the Scheme based on recommendations from the Audit Committee and Independent Directors. The transaction falls under Sections 230 to 232 of the Companies Act, 2013, and Section 2(6) of the Income Tax Act, 2025. It is subject to approvals from shareholders, creditors, and the Jaipur bench of the National Company Law Tribunal (NCLT).

Financial Profile of Entities

As per audited financial statements as on March 31, 2026, the Transferee Company reported total assets of ₹1,451.34 lakh and revenue from operations of ₹598.24 lakh. Its net worth stood at ₹1,174.95 lakh.

Atvo Agrochem’s net worth increased to ₹2,538.72 lakh as on June 30, 2026, following the issuance of 1,11,80,000 equity shares. Shubhshree Health Care’s net worth rose to ₹51.58 lakh in the same period after issuing 5,00,000 shares.

Business Operations

Atvo Agrochem is engaged in grain-based fuel ethanol manufacturing with an installed capacity of 120 KLPD using maize feedstock. The plant targets commissioning around November 2026.

Shubhshree Health Care operates a grain-based alcohol-beverage platform with a licensed Extra Neutral Alcohol (ENA) capacity of 190 KLPD. It is commissioning a first-phase capacity of 150 KLPD alongside a bottling license for 15,000 cases per day.

Shorya Business undertakes real estate development through its “Ananda Residency” project in Tonk, Rajasthan. The project spans approximately 13.33 hectares with over 452 plots for residential and commercial use.

Share Exchange Ratio

No cash consideration is payable. Shareholders will receive equity shares of face value ₹1 each in the Transferee Company:

• Atvo Agrochem: 58 shares for every 100 shares held
• Shubhshree Health Care: 5,202 shares for every 100 shares held
• Shorya Business: 4,160 shares for every 100 shares held

What the Numbers Show

The amalgamation significantly alters the capital structure of the listed entity. Promoter holding in Atvo Enterprises is set to rise from 55.80% to 70.65%, while public shareholding will dilute from 44.20% to 29.35%. This consolidation brings substantial asset value into the listed shell, primarily driven by Atvo Agrochem’s ₹15,807.10 lakh asset base, despite zero operational revenue for the ethanol unit as of March 2026.